This program equips you with practical knowledge and evidence-based practices to optimize patient care in respiratory care. Interested participants must apply to be considered for enrollment. All applications will be carefully reviewed. Priority will be given to applicants from the developing world who may not otherwise have access to this type of training opportunity. All applicants will be notified of their acceptance status upon review.
This educational course has been made possible through an unrestricted educational grant provided by
Aerogen
Important Dates
Application Period
March 11-21, 2026
Course Dates
June 7-14, 2026
Course Information
Description
Dr. Jim Fink’s International Aerosol Medicine Training Program developed by Dr. Arzu Ari is a comprehensive initiative aimed at advancing global expertise in the science and application of aerosol therapies. This program brings together healthcare professionals, researchers, and industry leaders to explore the latest innovations in aerosol delivery systems, inhalation therapies, and respiratory care.
Participants will gain in-depth knowledge of:
- Fundamentals of Aerosol Drug Delivery
- Aerosol Delivery Devices
- Aerosol Drug Delivery to Spontaneously Breathing Patients in Acute Care
- Aerosol Drug Delivery in Critical Pulmonary Care
- Aerosol Drug Delivery to Children
Through expert-led sessions, participants will develop the skills needed to optimize aerosol therapies across diverse patient populations and clinical settings.
At-A-Glance
Date: June 7-14, 2026
Cost: Free
Delivery: Online
Materials: No textbooks required
- Application Period is open March 11-21, 2026
- Course runs online June 7-14, 2026
Participants Will Gain In-Depth Knowledge
- Fundamentals of Aerosol Drug Delivery
- Aerosol Delivery Devices
- Aerosol Drug Delivery to Spontaneously Breathing Patients in Acute Care
- Aerosol Drug Delivery in Critical Pulmonary Care
- Aerosol Drug Delivery to Children
Program Benefits
- Through expert-led sessions, participants will gain the knowledge necessary to optimize aerosol therapies for diverse patient populations and clinical settings.
Investment in Your Professional Growth
The International Aerosol Medicine Training Program will advance your skills in aerosol drug delivery and respiratory care. Gain practical, evidence-based knowledge from leading experts in the field.
Dr. Jim Fink
Dr. Jim Fink
This innovative and comprehensive online training program will be dedicated to the legacy and teaching of Dr. Jim Fink, a renowned scholar and towering figure in aerosol research. Dr. Fink has made profound and lasting impacts through groundbreaking research, seminal publications, and transformative ideas. His pioneering work has not only advanced the frontiers of knowledge but has also shaped the discourse and practice within aerosol medicine influencing scholars, policymakers, and practitioners worldwide. Therefore, the program is designed to honor the invaluable contributions and intellectual prowess of Dr. Jim Fink, while inspiring and equipping the next generation of clinicians and scholars in aerosol medicine. Through a blend of lectures, discussions, and assignments, participants will have the opportunity to delve deeply into the key concepts and principles of safe and effective aerosol drug delivery championed by Dr. Fink.
Meet Your Instructor
Dr. Arzu Ari
Dr. Arzu Ari is a Regents' Professor and Associate Dean for Research at Texas State University (TXST). She holds a Ph.D. in Higher Education Administration and brings a diverse academic background with undergraduate degrees in Physical Therapy and Respiratory Care and master’s degrees in Public Health and Allied Health. Her scholarly achievements earned her tenure at both Georgia State University and TXST. She also directs the International Education Recognition System.
Since beginning her academic career in 2001, Dr. Ari has received more than 40 national and international awards. She has been recognized as a University Distinguished Professor and received the prestigious Regents’ Professor Award from the Texas State University System. She is a Fellow of the American College of Chest Physicians (FCCP) and the American Association for Respiratory Care (FAARC), honoring her contributions to pulmonary medicine and respiratory care.
Dr. Ari has held influential leadership roles in major professional organizations, including the American College of Chest Physicians, American Respiratory Care Foundation, International Society for Aerosols in Medicine, American Association for Respiratory Care, International Council for Respiratory Care, COPD Foundation, and Turkish Respiratory Society. Through these roles, she has led multidisciplinary teams worldwide to advance research, develop training programs, and strengthen international collaboration.
Her primary research focus is aerosol medicine. Over 25 years of basic, translational, and clinical research, she has advanced global understanding and practice of aerosol drug delivery by improving clinicians’ knowledge, identifying best practices in both spontaneous breathing and critical care settings, evaluating device performance, and developing new methods that enhance aerosol delivery for adults, children, infants, and newborns.
Dr. Ari’s research has been continuously funded by federal agencies, foundations, and industry partners. She has authored more than 200 publications and delivered over 350 presentations at 145 conferences worldwide. She is the lead author of A Guide to Aerosol Delivery Devices for Respiratory Therapists, 2nd Edition, downloaded more than 3 million times and translated into six languages. Her scholarly impact includes an H‑index of 32 with more than 3,700 citations. Her work published in leading journals such as The Lancet, Expert Opinion on Drug Delivery, and Pharmaceutics.
Dr. Ari also serves as Associate Editor for the Canadian Journal of Respiratory Therapy, and is a member of the Editorial Board for the Journal of Aerosol Medicine and Pulmonary Drug Delivery.